How Long Does It Take to See Results from Semaglutide?

What the STEP 1 data actually shows about early versus later loss

The STEP 1 trial is the most cited source on semaglutide's results, and for good reason: it followed 1,961 adults with obesity over 68 weeks under controlled conditions. Weight loss was not front-loaded. Participants lost weight steadily across the entire study period, with the rate of loss continuing well into the maintenance phase. That pattern matters, because it means judging semaglutide at eight or twelve weeks gives an incomplete picture.

In the first month, the dominant experience is often not weight loss itself but a shift in appetite. Food feels less urgent. Portions shrink naturally. Some people describe this as the most striking change they notice early on. The actual reduction in body weight tends to lag behind these appetite signals by a few weeks, simply because calorie changes take time to translate into measurable tissue loss.

By around twelve weeks (roughly the point where a prescriber is beginning to move the dose toward the higher titration steps) weight loss typically becomes more visible. By six months, many people have seen a significant proportion of the total loss they will achieve. But the trial data makes clear that loss at 68 weeks exceeds loss at 36 weeks: stopping early leaves results on the table. You can read more about how this plays out in practice on our semaglutide results overview.

Why the titration schedule shapes your results timeline

Semaglutide for weight management starts at 0.25 mg, not because 0.25 mg does much therapeutically, but because stepping up too quickly makes gastrointestinal side effects worse. The dose climbs roughly every four weeks: 0.25 mg, then 0.5 mg, 1.0 mg, 1.7 mg, and finally 2.4 mg. Some people tolerate the steps quickly; others need longer at an intermediate dose before moving on. A prescriber decides that, not a fixed timetable.

The practical consequence is that you will not be at the dose responsible for the trial's headline 15% figure until at least four months in, possibly longer. Results before that point are real but partial. If you are wondering how long it takes to see results from semaglutide and what drives those differences month by month, the honest answer is that results at two months are genuinely different from results at twelve months.

For a closer look at the week-by-week arc of what Wegovy users typically experience, the timeline of how long Wegovy takes to work covers the dose steps in more detail. NICE's appraisal of semaglutide (TA875) also sets out the six-month review threshold that guides clinical decision-making on whether to continue.

Factors that affect how quickly (and how much) weight changes

Trial averages are just that: averages. Individual results vary, and several things influence where on the curve someone lands. Starting BMI plays a role, people with higher starting weight often see larger absolute losses. Background activity and dietary habits matter too, not because semaglutide is ineffective without them but because the medicine works alongside, not instead of, lifestyle changes.

Sleep, stress, and any underlying metabolic conditions (such as insulin resistance or hypothyroidism) can also slow or modify the response. A prescriber reviewing your progress at repeat will consider these factors rather than comparing your results against a population average. If your pen lives in the fridge door and you take it on the same morning each week, that consistency in adherence also has a measurable effect: missed doses or irregular timing flatten the response curve.

It is worth reading the realistic expectations around Wegovy results before starting, so that the early weeks (when appetite shifts but the scales are slow) do not feel like the medicine is not working. Our clinical team field this question often, and the consistent message is: the first month is adjustment, the second is signal, and from month three onward the trajectory becomes much clearer.

When to flag slow progress to your prescriber

Not seeing any change by eight to ten weeks is worth raising with your prescriber, not because it guarantees a problem but because it is useful clinical information. It may indicate that the dose needs reviewing, that something else is affecting absorption or appetite, or simply that expectations need recalibrating. Our page on how long it takes to see results from Wegovy can help you understand what a typical response looks like at each stage before that conversation.

NICE's guidance sets a formal review point at six months: less than 5% weight loss on the maintenance dose is the threshold at which continuing treatment should be reassessed. That is a clinical decision, made with your prescriber, with access to your full history. It is not something to self-manage by adjusting the dose or stopping abruptly.

You can explore what a full course of Wegovy typically looks like, including the cost of ongoing treatment, on the Wegovy cost page. If you are ready to discuss your own situation with a prescriber, check your eligibility with us, consultations are free, reviewed the same day by a GPhC-registered prescriber, and there is no subscription commitment.